Earthquake, Tsunami Disrupt Pharma Manufacturing in Japan
This article was originally published in The Gold Sheet
Executive Summary
TOKYO - Following a massive earthquake, tsunami, and potential nuclear disaster, Japan's leading pharmaceutical companies like Astellas Pharma Inc. are joining the rest of the country in assessing and responding to the damage.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.